Saratoga Investment Valuation
Is SAR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SAR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SAR ($26.07) is trading below our estimate of fair value ($43.17)
Significantly Below Fair Value: SAR is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SAR?
Key metric: As SAR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is SAR's PE Ratio? | |
|---|---|
| PE Ratio | 17x |
| Earnings | US$21.18m |
| Market Cap | US$354.40m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7x |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does SAR's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 45.7x | ||
IPXX Inflection Point Acquisition II | 28.2x | n/a | US$335.0m |
GPAT GP-Act III Acquisition | 67.7x | n/a | US$362.3m |
SLVR SILVERspac | 30.9x | n/a | US$327.5m |
GSAQ Global Synergy Acquisition | 56x | n/a | US$323.4m |
SAR Saratoga Investment | 17x | 30.2% | US$354.4m |
Price-To-Earnings vs Peers: SAR is good value based on its Price-To-Earnings Ratio (17x) compared to the peer average (47.9x).
Price to Earnings Ratio vs Industry
How does SAR's PE Ratio compare vs other companies in the US Capital Markets Industry?
| 23 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
ADX Adams Diversified Equity Fund | 3.6x | n/a | US$2.50b |
CET Central Securities | 4.5x | n/a | US$1.32b |
GAM General American Investors Company | 4.1x | n/a | US$1.16b |
MUDS Mudrick Capital Acquisition Corporation II | 3.4x | n/a | US$401.64m |
| 23 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: SAR is good value based on its Price-To-Earnings Ratio (17x) compared to the US Capital Markets industry average (24.1x).
Price to Earnings Ratio vs Fair Ratio
What is SAR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 17x |
| Fair PE Ratio | 15.7x |
Price-To-Earnings vs Fair Ratio: SAR is expensive based on its Price-To-Earnings Ratio (17x) compared to the estimated Fair Price-To-Earnings Ratio (15.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$26.07 | US$26.05 -0.08% | 6.0% | US$29.00 | US$25.00 | n/a | 5 |
| Nov ’25 | US$23.23 | US$26.05 +12.1% | 6.0% | US$29.00 | US$25.00 | n/a | 5 |
| Oct ’25 | US$23.03 | US$25.04 +8.7% | 7.7% | US$29.00 | US$23.00 | n/a | 6 |
| Sep ’25 | US$23.57 | US$25.04 +6.2% | 7.7% | US$29.00 | US$23.00 | n/a | 6 |
| Aug ’25 | US$23.01 | US$25.04 +8.8% | 7.7% | US$29.00 | US$23.00 | n/a | 6 |
| Jul ’25 | US$22.52 | US$25.25 +12.1% | 7.2% | US$29.00 | US$23.00 | n/a | 7 |
| Jun ’25 | US$23.74 | US$25.25 +6.4% | 7.2% | US$29.00 | US$23.00 | n/a | 7 |
| May ’25 | US$23.70 | US$26.04 +9.9% | 6.5% | US$29.00 | US$24.00 | n/a | 7 |
| Apr ’25 | US$23.12 | US$26.04 +12.6% | 6.5% | US$29.00 | US$24.00 | n/a | 7 |
| Mar ’25 | US$23.61 | US$26.04 +10.3% | 6.5% | US$29.00 | US$24.00 | n/a | 7 |
| Feb ’25 | US$23.01 | US$26.04 +13.1% | 6.5% | US$29.00 | US$24.00 | n/a | 7 |
| Jan ’25 | US$25.86 | US$27.61 +6.8% | 5.8% | US$30.00 | US$25.00 | n/a | 7 |
| Dec ’24 | US$26.11 | US$27.61 +5.7% | 5.8% | US$30.00 | US$25.00 | n/a | 7 |
| Nov ’24 | US$23.92 | US$27.61 +15.4% | 5.8% | US$30.00 | US$25.00 | US$23.23 | 7 |
| Oct ’24 | US$25.70 | US$28.11 +9.4% | 5.5% | US$30.00 | US$25.00 | US$23.03 | 7 |
| Sep ’24 | US$25.75 | US$28.11 +9.2% | 5.5% | US$30.00 | US$25.00 | US$23.57 | 7 |
| Aug ’24 | US$26.68 | US$28.11 +5.3% | 5.5% | US$30.00 | US$25.00 | US$23.01 | 7 |
| Jul ’24 | US$26.99 | US$27.38 +1.4% | 5.1% | US$30.00 | US$25.00 | US$22.52 | 8 |
| Jun ’24 | US$28.64 | US$27.38 -4.4% | 5.1% | US$30.00 | US$25.00 | US$23.74 | 8 |
| May ’24 | US$24.38 | US$28.19 +15.6% | 2.2% | US$29.00 | US$27.00 | US$23.70 | 8 |
| Apr ’24 | US$25.28 | US$28.36 +12.2% | 1.6% | US$29.00 | US$28.00 | US$23.12 | 7 |
| Mar ’24 | US$27.49 | US$28.36 +3.2% | 1.6% | US$29.00 | US$28.00 | US$23.61 | 7 |
| Feb ’24 | US$27.04 | US$28.36 +4.9% | 1.6% | US$29.00 | US$28.00 | US$23.01 | 7 |
| Jan ’24 | US$25.49 | US$27.71 +8.7% | 4.3% | US$29.00 | US$25.00 | US$25.86 | 7 |
| Dec ’23 | US$26.90 | US$27.75 +3.2% | 4.6% | US$29.00 | US$25.00 | US$26.11 | 6 |
| Nov ’23 | US$22.93 | US$27.75 +21.0% | 4.6% | US$29.00 | US$25.00 | US$23.92 | 6 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
Investor
SEK 906.7b
A private equity firm specializing in mature, middle market, buyouts and growth capital investments.
IVSB.F
SEK 26.00
7D
-3.9%
1Y
28.7%
FinVolution Group
US$1.6b
Operates in the online consumer finance industry.
FINV
US$6.29
7D
8.1%
1Y
38.5%
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
IX
JP¥107.82
7D
-0.5%
1Y
18.6%